Lee M W, Deppe S A, Sipperly M E, Barrette R R, Thompson D R
Department of Surgery, Mercy Hospital of Pittsburgh, Pennsylvania.
J Neurotrauma. 1994 Jun;11(3):325-31. doi: 10.1089/neu.1994.11.325.
The purpose of this study was to evaluate the role of barbiturate therapy as an adjunctive treatment for control of intracranial hypertension when conventional methods failed. To this end, a retrospective chart review was conducted on 21 neurosurgical trauma patients with uncontrolled intracranial pressure (ICP) admitted to a trauma/intensive care unit. In this patient population, the overall mortality was 48%. Control of ICP was achieved in 67% of patients. The survival of patients experiencing ICP control with barbiturate coma was better than those patients who failed therapy (71% vs 14%, p = 0.021). Thus, in a subgroup of neurosurgical trauma patients who are refractory to conventional management of elevated ICP, barbiturates appear to improve survival, suggesting that this therapy has an important role in the management of neurotrauma patients.
本研究的目的是评估当传统方法无效时,巴比妥类药物疗法作为控制颅内高压辅助治疗的作用。为此,对入住创伤/重症监护病房的21例颅内压(ICP)未得到控制的神经外科创伤患者进行了回顾性病历审查。在该患者群体中,总死亡率为48%。67%的患者实现了ICP控制。通过巴比妥类药物昏迷实现ICP控制的患者生存率高于治疗失败的患者(71%对14%,p = 0.021)。因此,在一组对传统ICP升高管理方法难治的神经外科创伤患者中,巴比妥类药物似乎能提高生存率,这表明该疗法在神经创伤患者的管理中具有重要作用。